INGEVITY MRI
Report
- Report Number
- 2124215-2023-55902
- Event Type
- Injury
- Date Received
- October 10, 2023
- Date of Event
- September 27, 2023
- Report Date
- December 19, 2023
- Manufacturer
- BOSTON SCIENTIFIC CORPORATION
- Product Code
- NVN
- UDI-DI
- 00802526523427
- PMA / PMN Number
- P150012/S000
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MN, US
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
ADDED CODE FOR UN-RETRIEVED DEVICE FRAGMENTS UPON REVIEW BY OUR MEDICAL TEAM.
IT WAS REPORTED THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) SYSTEM HAD A STORED SIGNAL ARTIFACT MONITOR (SAM) EPISODE. TECHNICAL SERVICES (TS) EXAMINED DEVICE EPISODE DATA AND FOUND THAT THERE WAS OVERSENSING OF RESPIRATORY RATE TREND (RRT) NOISE WITH INHIBITION OF PACING FOR ONE BEAT ON THE RIGHT ATRIAL (RA) LEAD CHANNEL. THE PACING IMPEDANCE VALUES FOR THE RA LEAD WERE GREATER THAN 3000 OHMS, WHICH WAS OUT OF RANGE. THE PATIENT WAS TESTED IN CLINIC, INCLUDING ISOMETRICS AND MANIPULATIONS, AND IT WAS FOUND THAT THE SENSING ON THE RA LEAD WAS LOW AND INTERMITTENT WITH NO CAPTURE AT MAXIMUM OUTPUT. IT WAS NOTED THAT THE PLAN IS TO EXTRACT THE RA LEAD AT A LATER DATE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. CURRENTLY, THIS ICD SYSTEM REMAINS IN SERVICE. ACCORDING TO ADDITIONAL INFORMATION, THIS LEAD WAS EXPLANTED DUE TO A FRACTURE AND SUBSEQUENTLY REPLACED WITH A NEW RA LEAD. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. AS OF TODAY, THIS PRODUCT HAS NOT BEEN RECEIVED BY BOSTON SCIENTIFIC FOR FURTHER INVESTIGATION.
IT WAS REPORTED THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) SYSTEM HAD A STORED SIGNAL ARTIFACT MONITOR (SAM) EPISODE. TECHNICAL SERVICES (TS) EXAMINED DEVICE EPISODE DATA AND FOUND THAT THERE WAS OVERSENSING OF RESPIRATORY RATE TREND (RRT) NOISE WITH INHIBITION OF PACING FOR ONE BEAT ON THE RIGHT ATRIAL (RA) LEAD CHANNEL. THE PACING IMPEDANCE VALUES FOR THE RA LEAD WERE GREATER THAN 3000 OHMS, WHICH WAS OUT OF RANGE. THE PATIENT WAS TESTED IN CLINIC, INCLUDING ISOMETRICS AND MANIPULATIONS, AND IT WAS FOUND THAT THE SENSING ON THE RA LEAD WAS LOW AND INTERMITTENT WITH NO CAPTURE AT MAXIMUM OUTPUT. IT WAS NOTED THAT THE PLAN IS TO EXTRACT THE RA LEAD AT A LATER DATE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. CURRENTLY, THIS ICD SYSTEM REMAINS IN SERVICE. ACCORDING TO ADDITIONAL INFORMATION, THIS LEAD WAS EXPLANTED AND REPLACED WITH A NEW RA LEAD. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. AS OF TODAY, THIS PRODUCT HAS NOT BEEN RECEIVED BY BOSTON SCIENTIFIC FOR FURTHER INVESTIGATION.
IT WAS REPORTED THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) SYSTEM HAD A STORED SIGNAL ARTIFACT MONITOR (SAM) EPISODE. TECHNICAL SERVICES (TS) EXAMINED DEVICE EPISODE DATA AND FOUND THAT THERE WAS OVERSENSING OF RESPIRATORY RATE TREND (RRT) NOISE WITH INHIBITION OF PACING FOR ONE BEAT ON THE RIGHT ATRIAL (RA) LEAD CHANNEL. THE PACING IMPEDANCE VALUES FOR THE RA LEAD WERE GREATER THAN 3000 OHMS, WHICH WAS OUT OF RANGE. THE PATIENT WAS TESTED IN CLINIC, INCLUDING ISOMETRICS AND MANIPULATIONS, AND IT WAS FOUND THAT THE SENSING ON THE RA LEAD WAS LOW AND INTERMITTENT WITH NO CAPTURE AT MAXIMUM OUTPUT. IT WAS NOTED THAT THE PLAN IS TO EXTRACT THE RA LEAD AT A LATER DATE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. CURRENTLY, THIS ICD SYSTEM REMAINS IN SERVICE. ACCORDING TO ADDITIONAL INFORMATION, THIS LEAD WAS EXPLANTED DUE TO A FRACTURE AND SUBSEQUENTLY REPLACED WITH A NEW RA LEAD. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. AS OF TODAY, THIS PRODUCT HAS NOT BEEN RECEIVED BY BOSTON SCIENTIFIC FOR FURTHER INVESTIGATION.
IT WAS REPORTED THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) SYSTEM HAD A STORED SIGNAL ARTIFACT MONITOR (SAM) EPISODE. TECHNICAL SERVICES (TS) EXAMINED DEVICE EPISODE DATA AND FOUND THAT THERE WAS OVERSENSING OF RESPIRATORY RATE TREND (RRT) NOISE WITH INHIBITION OF PACING FOR ONE BEAT ON THE RIGHT ATRIAL (RA) LEAD CHANNEL. THE PACING IMPEDANCE VALUES FOR THE RA LEAD WERE GREATER THAN 3000 OHMS, WHICH WAS OUT OF RANGE. THE PATIENT WAS TESTED IN CLINIC, INCLUDING ISOMETRICS AND MANIPULATIONS, AND IT WAS FOUND THAT THE SENSING ON THE RA LEAD WAS LOW AND INTERMITTENT WITH NO CAPTURE AT MAXIMUM OUTPUT. IT WAS NOTED THAT THE PLAN IS TO EXTRACT THE RA LEAD AT A LATER DATE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. CURRENTLY, THIS ICD SYSTEM REMAINS IN SERVICE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 335733 | INGEVITY MRI | IMPLANTABLE LEAD | NVN | BOSTON SCIENTIFIC CORPORATION | 7740 | 704506 | 00802526523427 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 17 YR | Male | Hospitalization| R |